| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
n
kMax-Delbrück-Center for Molecular Medicine, D-13122 Berlin, Germany [N. P. K., J. M., S. K., G. B., B. A., A. O., M. Z., P. B.], and Institute of Molecular Genetics, 166 37 Prague 6, Czech Republic [P. B.]
Nuclear receptors represent key regulators in cell proliferation, differentiation, and development. Here we demonstrate that the nuclear orphan receptor TR4 is highly expressed in hematopoietic cells and tissues and have analyzed the impact of TR4 in this cell compartment. We show that TR4, when ectopically expressed in bone marrow cells via retrovirus vector, promotes proliferation of myeloid progenitor cells. Cells represent promyelocytes as judged by morphological features, expression of cell surface molecules, and specific markers like Mim-1 and CAAT/enhancer binding protein ß. We also demonstrate that the growth promoting activity of TR4 is not exclusively dependent on its association with DNA, because expression of a mutated TR4 version devoid of its DNA binding domain exhibits a similar proliferative potential as wild-type TR4. In conclusion, these data position the orphan receptor TR4 as an important regulator of myeloid progenitor cell proliferation and development.
This article has been cited by other articles:
![]() |
M. D. M. Huq, P. Gupta, N.-P. Tsai, and L.-N. Wei Modulation of Testicular Receptor 4 Activity by Mitogen-activated Protein Kinase-mediated Phosphorylation Mol. Cell. Proteomics, November 1, 2006; 5(11): 2072 - 2082. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakajima, S. Fujino, G. Nakanishi, Y.-S. Kim, and A. M. Jetten TIP27: a novel repressor of the nuclear orphan receptor TAK1/TR4 Nucleic Acids Res., August 9, 2004; 32(14): 4194 - 4204. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bekri, A. May, P. D. Cotter, A. I. Al-Sabah, X. Guo, G. S. Masters, and D. F. Bishop A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia Blood, July 15, 2003; 102(2): 698 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, X. Wang, T. Dong, E. Kim, W.-J. Lin, and C. Chang Identification of a Novel Testicular Orphan Receptor-4 (TR4)-associated Protein as Repressor for the Selective Suppression of TR4-mediated Transactivation J. Biol. Chem., February 21, 2003; 278(9): 7709 - 7717. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |